Carrageenan-induced thermal hyperalgesia in the mouse: Role of nerve growth factor and the mitogen-activated protein kinase pathway

Brain Research

Volumn 876, Issue 1-2, 2000, Pages 48-54

  Sammons, Melanie J ^a   Raval, Pravin ^a   Davey, Philip T ^a   Rogers, Derek ^a   Parsons, Andrew A ^a   Bingham, Sharon ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Carrageenan; Hyperalgesia; Inflammation; MAPK; Mouse; NGF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CARRAGEENAN; INDOMETACIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MORPHINE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; ENZYME INHIBITION; HEAT SENSITIVITY; HYPERALGESIA; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANALGESICS, OPIOID; ANIMALS; CARRAGEENAN; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; FLAVONOIDS; HEAT; HINDLIMB; HYPERALGESIA; INDOMETHACIN; INFLAMMATION; MALE; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHINE; NERVE GROWTH FACTOR; TIME FACTORS;

EID: 0034623098     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02596-8     Document Type: Article

References (37)

1. Amann R., Schuligoi R., Herzeg G., Donnerer J. Intraplantar injection of nerve growth factor into the rat hind paw: local edema and effects on thermal nociceptive threshold. Pain. 64:1996;323-329.
2. Andreev N.Y., Dimitrieva N., Koltzenberg M., McMahon S.B. Peripheral administration of nerve growth factor in adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post ganglionic neurons. Pain. 63:1995;109-115.
3. Bennett G.S., Brain S.D. Nerve growth factor induces an immediate and also a late phase of oedema formationin the skin. Br. J. Pharmacol. 119:1996;55P.
4. Bennett G.S., Al Rashed S., Hoult J.R.S., Brain S.D. Nerve growth factor induced hyperalgesia is dependent on circulatind neurtophils. Pain. 77:1998;315-322.
5. Blackham A., Hall D.E., Mann J., Woods A.M. Effect of cyclo-oxygenase inhibitors in models of acute inflammation. Agents-Actions-Suppl. 4:1979;193-201.
6. Buritova J., Chapman V., Honore P., Bessen J.-M. The contribution of peripheral bradykinin B2 receptors to carrageenan-evoked oedema and spinal c-Fos expression in rats. Eur. J. Pharmacol. 320:1997;73-80.
7. Coderre T.J., Melzack R. Central neural mediators of secondary hyperalgesia following heat injury in rats: neuropeptides and excitatory amino acids. Neurosci. Lett. 131:1991;71-74.
8. Della Seta D., De Acetis L., Aloe L., Alleva E. NGF effects on hot plate behaviours in mice. Pharmacol. Biochem. Behav. 49:1994;701-705.
9. Di-Rosa M., Sorrentino L. The mechanism of the inflammatory effect of carrageenan. Eur. J. Pharmacol. 4:1968;340-342.
10. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92:1995;7686-7689.
11. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
12. Henriques M.G.M.O., Silva P.M.R., Martins M.A., Flores C.A., Cunha F.Q., Assreuy-Filho J., et al. Mouse paw oedema. A new model for inflammation? Braz. J. Med. Bio. Res. 20:1987;243-249.
13. Hoffmeyer A., Grosse-Wilde A., Flory E., Neufeld B., Kunz M., Rapp U.R., et al. Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor necrosis factor a gene expression in T lymphocytes. J. Biol. Chem. 274:1999;4319-4327.
14. Horigome K., Pryor J.C., Bullock E.D., Johnson E.M. Jr. Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. J. Biol. Chem. 268:1993;14881-14887.
15. Ianaro A., O’Donnell C.A., Di Rosa M., Liew F.Y. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology. 82:1994;370-375.
16. Ji R.-R., Baba H., Brenner G.J., Woolf C.J. Nociceptive specific activation of ERK in spinal neurones contributes to pain hypersensitivity. Nature Neurosci. 2:1999;1114-1119.
17. Kocher L., Anton F., Reeh P.W., Handwerker H.O. The effect of carrageenan-induced inflammation on the sensitivity of unmyelinated skin nociceptors in the rat. Pain. 29:1987;363-373.
18. Levi-Montalcini R., Skaper S.D., Dal Toso R., Petrelli L., Leon A. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci. 19:1996;514-520.
19. Levy L. Carrageenan paw oedema in the mouse. Life. Sci. 8:1969;601-606.
20. Lewin G.R., Mendell L.M. Nerve growth factor and nociception. Trends Neurosci. 16:1993;353-359.
21. Lewin G.R., Rueff A., Mendell M. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur. J. Neurosci. 6:1994;1903-1912.
22. Lin W.W., Chen B.C. Induction of cyclo-oxygenase-2 expression by methylarachidonyl fluorophosphonate in murine J774 macrophages: roles of protein kinase C, ERKs and p38 MAPK. Br. J. Pharmacol. 126:(6):1999;1419-1425.
23. Lindsay R.M., Harmar A.J. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature. 337:(6205):1989;362-364.
24. Marshall J.S., Stead R.H., Mcsharry C., Nielsen L., Bienenstock J. The role of mast cell degranulation products in mast cell hyperplasia. I. Mechanism of action of nerve growth factor. J. Immunol. 144:(5):1990;1886-1892.
25. McMahon S.B. NGF as a mediator of inflammatory pain. Phil. Trans. R. Soc. Lond. 351:1996;431-440.
26. McMahon S.B., Bennett D.L.H., Priestly J.V., Shelton D.L. The biological effects of endogenous NGF in adult sensory neurons revealed by a TrkA IgG fusion molecule. Nat. Med. 1:1995;774-780.
27. Oh-Ishi S. Analysis of chemical mediators involved in acute inflammatory reaction with the rat pleurisy model. Nippon Yakurigaku Zasshi-Folia Pharmacologica Japonica. 110:(2):1997;59-68.
28. Local hormones, inflammation and allergy. Rang H.P., Dale M.M. Pharmocology. second ed:1994;257-261 Churchill Livingston. Chapter 11.
29. Rueff A., Mendell L.M. Nerve growth factor and NT-5 induce increased thermal sensitivity of cutaneous nociceptors in vitro. J. Neurophys. 76:(5):1996;3593-3596.
30. Salvemini D., Wang Z.-Q., Wyatt P.S., Bourdon D.M., Marino M.H., Manning P.T., et al. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol. 118:1996;829-838.
31. Safieh-Garabedian B., Poole S., Allchorne A., Winter J., Woolf C.J. Contribution of interleukin 1-beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br. J. Pharmacol. 115:1995;1265-1275.
32. Taiwo Y.O., Coderre T.J., Levine J.D. The contribution of training to sensitivity in the nociceptive paw-withdrawal test. Brain. Res. 487:1989;148-151.
33. Tal M., Liberman R. Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw. Neurosci. Lett. 221:(2-3):1997;129-132.
34. Weskamp G., Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in the brain and in peripheral tissues. J. Neurochem. 48:1987;1779-1786.
35. Woolf C.J. Phenotypic modification of primary sensory neurons-the role of nerve growth factor in the production of persistent pain. Phil. Trans. R. Soc Lond-Series B. 351:(1338):1996;441-448.
36. Woolf C.J., Safieh-Garabedian B., Ma Q.-P., Crilly P., Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience. 62:1994;327-331.
37. Woolf C.J., Ma Q.-P., Allchorne A., Poole S. Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J. Neurosci. 16:1996;2716-2723.